Introduction:
Methemoglobinemia (MetHb) is an uncommon but a well‐known side effect of multiple drugs. 8 amino quinolones (Primaquine) are known to produce toxic ferric form of the hemoglobin. Primaquine is also known to inhibit the MetHb reductase enzyme. Primaquine is used in Pneumocystis cariniiProphylaxis and treatment in sulfa intolerant immuno‐compromised population.
Case Presentation:
Our patient is a 45‐year‐old gentleman was admitted to outside facility for pneumonia and was treated with Ceftriaxone and Azithromycin. Due to his risk factors and second pneumonia episode within one‐year he was tested and diagnosed with Acquired Immunodeficiency Syndrome (AIDS). Due to lack of improvement in his symptoms over 3 days he was transferred to our hospital. Patient was diagnosed with Pneumocystis cariniiPneumonia (PCP) and treated with Methyl prednisone, Primaquine and Clindamycin. Trimethoprim/Sulfamethoxazole (TMP/SMX) was not used secondary to worsening acute renal failure. Patient initially improved and symptomatically but continued to use very high inspiratory oxygen fraction (FiO2) due to pulse oximetry readings of 85‐86% which improved to 90 percent with 100% oxygen. Patient also had worsening symptoms of dyspnea and central cyanosis was noted. Arterial blood gas was done at this time which showed hemoglobin saturation of 94% and partial pressure of oxygen to be >200. At this time Methemoglobin (MetHb) level was checked which was elevated at 11%. Patient was treated with Methylene blue using half of the therapeutic dose (0.5mg/kg – due to renal failure) and MetHb was observed to reduce over the next day. Patient’s pulse Oximetry was noted to improve to 95‐98%. Patient showed clinical improvement and his FiO2 was also weaned down within 24 hours. Patient’s treatment regimen was then changed to TMP/SMX, since renal function had stabilized.
Discussion:
Primaquine induced Methemoglobinemia was been described on multiple occasions in Malaria literature. A dose of more than 60mg has been associated with MetHb. In patients with HIV/ AIDS a high clinical suspicion helps in diagnosing this relatively rare entity due to multiple other etiologies for hypoxia. In a Randomized Controlled trial done by the Safrin et al the treatment efficacy of all treatment regimens for PCP was found to be similar but MetHb incidence was higher in Primaquine group.
Conclusions:
Elevated MetHb levels definitely played a role in this patient’s worsening clinical status since his symptoms and oxygen requirement improved within 1 day of initiation of treatment for MetHb. High Clinical suspicion helps in diagnosing this uncommon entity.